Results 231 to 240 of about 195,940 (363)

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Ventricular Assist Device Program Gains Prestigious Accreditation [PDF]

, 2009

core   +1 more source

Factors associated with the use of guideline-directed medical therapy in patients with left ventricular assist device. [PDF]

Eur J Heart Fail
Chedid El Helou M, Nandar PP, Tereshchenko LG, Jacob M, Bhat P, Vest AR, Bhattacharya S, Hsich E, Collier P, Tang WHW, Soltesz E, Tong MZ, Starling RC, Martyn T.   +13 more
europepmc   +1 more source

Magnetic Suspension Controls for a New Continuous Flow Ventricular Assist Device

, 1997
E. Hilton, Paul E. Allaire, M. Baloh, Eric H. Maslen, G. Bearnson, Pratap S. Khanwilkar, Donald B. Olsen   +6 more
openalex   +1 more source

eGFR slope as predictor of mortality in heart failure patients

ESC Heart Failure, Volume 12, Issue 2, Page 1217-1226, April 2025.
Abstract Aims Heart failure (HF) leads to an imbalance between heart and kidney function, resulting in poor outcomes. However, the prognostic significance of the estimated glomerular filtration rate (eGFR) trajectory in HF patients remains unclear. We analysed electronic health records (EHRs) of real‐world HF patients, assessing eGFR trajectories and ...
Sofie Verstreken, Monika Beles, Clara L. Oeste, Ana Moya, Imke Masuy, Riet Dierckx, Ward Heggermont, Jeroen Dauw, Dries Hens, Jozef Bartunek, Marc Vanderheyden   +10 more
wiley   +1 more source

The approach to placement of a continuous-flow intracorporeal ventricular assist device in small left ventricle. [PDF]

JHLT Open
El-Andari R, Dion J, Conway J, Pidborochynski T, Carter L, Singh G, MacArthur R, Meyer S, Jonker D, Freed DH, Buchholz H.   +10 more
europepmc   +1 more source

A Remote Monitoring System for Patients with Implantable Ventricular Assist Devices with a Personal Handy Phone System

, 1999
Eiji Okamoto, MIZUKI SHIMANAKA, Shinya Suzuki, KAZUHIRO BABA, Yoshinori Mitamura   +4 more
openalex   +1 more source

Diagnosis and management of left ventricular assist device valve-endocarditis: LVAD valve replacement [PDF]

, 2000
Koen C de Jonge, Horst Laube, Pascal M. Dohmen, Velimir Ivančević, Wolfgang Konertz   +4 more
openalex   +1 more source

Pulsatile Ventricular Assist Platform:A Novel Surgically Implanted Ventricular Assist Device [PDF]

Bastos, Marcelo B., Deniz, Ezin, Dogan, Günes, Knigge, Sara, Malchin, Oren, Schmitto, Jan D.   +5 more
core   +1 more source

ICD Lead Mechanical Interference From Left Ventricular Assist Device. [PDF]

JACC Case Rep
Mahajan P, Joshi A, Al-Mohamad T, Coll R, Cossu SF.   +4 more
europepmc   +1 more source